References
Wang EE, Milner RA, Navas L, Maj H. Observer agreement for respiratory signs and oximetry in infants hospitalized with lower respiratory infections. Am Rev Respir Dis 1992;145:106–109.
Mathew JL. Hypertonic saline nebulization for bronchiolitis. Indian Pediatr 2008;45:987–989.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008; 4:CD006458.
Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr. 2010;157:630–634.
Zhang L, Mendoza-Sassi RA, Wainwright C, Klassen TP. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013;7: CD006458.
Hartling L, Bialy LM, Vandermeer B, Tjosvold L, Johnson DW, Plint AC, et al. Epinephrine for bronchiolitis. Cochrane Database Syst Rev. 2011;6:CD003123.
Sharma BS, Gupta MK, Rafik SP. Hypertonic (3%) saline for acute viral bronchiolitis: A randomized trial. Indian Pediatr. 2013;50:743–747.
Gupta S, Ahmed F, Lodha R, Gupta YK, Kabra SK. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial. J Trop Pediatr. 2012;58:375–381.
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, et al.; ISIS Study Group. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA. 2012;307:2269–2277.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mathew, J.L., Shivbalan, S. & Sehgal, V. 7% Hypertonic saline in acute bronchiolitis: A Randomized Controlled Trial . Indian Pediatr 51, 221–222 (2014). https://doi.org/10.1007/s13312-014-0372-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-014-0372-5